# Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

> **NCT00971581** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 52 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** FDC KETOPROFEN+OMEPRAZOLE

## Key facts

- **NCT ID:** NCT00971581
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2010-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971581, "Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00971581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*